Indian Journal of Obstetrics and Gynecology Research

Print ISSN: 2394-2746

Online ISSN: 2394-2754

CODEN : IJOGCS

Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 465

PDF Downloaded: 187


Get Permission Gautam, Malik, and Jain: Early diagnosis of placenta accreta in case of mid trimester postabortal haemorrhage with previous 3 cesarean sections


Introduction

Placenta accreta is a complication of pregnancy can be associated with maternal mortality. During development of placenta, trophoblastic invasion occur beyond nitabuch layer (fibrinoid layer), depend on depth of placental invasion, it classify as into placenta accreta vera (placenta abut to the myometrium without breaching), placenta increta (placenta invade subtotally within the myometrium), and placenta percreta(fully invasion inside the myometrium, inclusive of perforation beyond the uterine serosa).1, 2 Placenta accreta frequently manifests as excessive vaginal bleeding and difficulty releasing the placenta during the third stage of labor, very rarely mid trimester pregnancy termination, may lead to profuse postabortal haemorrhage. Approximately 3000 to 5000ml of blood loss occur during delivery of women with placenta accrete.3

Incidence of placenta accreta spectrum has been reported 1 in 2500–7000 pregnancies.4 For women with placenta previa, the risk of placenta accreta increases as 3% with first caesarean, 11% with second caesarean, 40% with third caesarean, 61% with fourth caesarean, and 67% with fifth or more.5, 6 The ultrasound and MRI have similar accuracy in diagnosis of PAS. Final diagnosis is confirmed by histopathology examination. Laparoscopic or Abdominal hysterectomy is the treatment for placenta accreta diagnosed in first trimester abortion. Early diagnosis, quick decision, timely intervention can manage this emergent condition with favourable outcomes.

Case Report

A 36 years old patient P3L3A1 with history of prior 3 LSCS with retained placenta with profuse bleeding per vaginum with history of expulsion of fetus (18 week) on the way to hospital, presented to labor room. Patient was unbooked and uninvestigated. She had a history of bleeding per vaginum in her antenatal period. On general examination, PR -118/ min, BP- 90 / 60mm, saturation 98% at room air. There is no pallor, no icterus, no cyanosis, no clubbing, no pedal oedema. On per abdominal examination- uterus not well contracted, below umbilicus, on per vaginum examination- os open, placenta in situ, torrential bleeding per vaginum present. Initial resuscitation done along with oxytocic given but no sign of placental separation was there and bleeding was continued. On the basis of torrential bleeding and history of previous three caesarean deliveries, patient is immediately shifted to the operation theatre for exploratory laparotomy in view or provisional diagnosis of a morbidly adherent placenta with torrential haemorrhage.

Intraoperative finding

Anterior surface of lower uterine segment of uterus fully covered with engorged blood vessels.(Figure 1) Bladder was spared. Decision of subtotal laparotomy taken in view of morbidly adherent placenta. Subtotal hysterectomy was done, haemostasis achieved. 2 unit PCV transfused intraoperatively and patient shifted to ICU postoperatively. She was recovered well and discharged on postoperative day (pod) 6 under satisfactory condition. The specimen was sent for histopathological examination.

Figure 1

Lower uterine segment covered with engorged vessel

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/1dac366d-5457-483d-b887-c53be25366a9/image/26cf5cfc-2a1c-4c01-83ba-12325a7fd9d4-uimage.png

Cut sections

Placenta is implanted at the lower uterine segment, adherent to the uterine wall.(Figure 2, Figure 3)

Figure 2

First image of cut section of uterus with adhere placenta

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/1dac366d-5457-483d-b887-c53be25366a9/image/41325dab-c693-4ac8-8185-a6551464a62b-uimage.png

Figure 3

Second image of cut section of uterus with adhere placenta

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/1dac366d-5457-483d-b887-c53be25366a9/image/0719da8d-f389-4605-aa5c-249e884cac60-uimage.png

Table 1

Recommendations regarding management of placenta accrete spectrum

Recommendations

Resource setting

Strength and Quality of evidence of recommendation

For women who want to save their fertility, leaving the placenta in place and agreeing to long-term continuous follow up in centres with adequate expertise is an option.

High

Strong and Moderate

The difficult manual removal of the placenta should be omitted.

All

Strong and high

If a conservative treatment is attempted in cases of Placenta accrete spectrum disorders diagnosed antenatally, preoperative ultrasound should be confirmed the proper location of the placenta and the experienced surgical team and equipment should be ready for an emergency hysterectomy.

High

Strong and Moderate

After delivery of the baby, and only in cases with no clinical evidence of invasive placenta accrete spectrum disorders, the surgeon may carefully attempt to remove the placenta by the use of uterotonics and controlled cord traction

All

Strong and low

Postop. Antibiotic therapy (clindamycin or amoxicillin and clavulanic acid in case of penicillin allergy) should be administered prophylactically to minimize the infection risk when the placenta is left in situ.

High

Weak and low

There is no recommendation of use of methotrexate until further evidence is available on its efficacy and safety

High

Strong and Moderate

There is no recommendation to do Preventive surgical or radiological uterine devascularisation.

High

Weak and low

MRI and serum β -hCG are used to monitor conservative management cases, is insufficient evidence to recommend.

High

Weak and low

High risk of recurrence of PAS disorders should be advised to women who want another pregnancy.

All

Strong and high

The hemostasis efficacy is operator dependent, making one-step conservative surgery less reproducible than other conservative management approaches.

High

Weak and low

Histopathological examination

An enlarged specimen of uterus of 9x8x6cm with adherent placenta in the lower segments section taken from upper segment of uterus show endometrium lined by secretory endometrium with decidualization and few trophoblastic cells. Myometrium shows hypertrophy with Congested blood vessels and oedema, Section from adherent placenta show Chorionic villi adherent to the myometrium however it is not invading the myometrium. Suggestive of Pregnancy related Changes in Uterus with placenta accreta.

Discussion

Placenta accreta spectrum (PAS), earlier known as morbidly adherent placenta. Women with one previous cesarean section, rate of placenta accreta increased from 0.3% to 6.77% for women with ≥5 cesarean deliveries.7, 8 Women, who has placenta previa, the risk of placenta accreta increases as 3% with first cesarean, 11% with second cesarean, 40% with third cesarean, 61% with fourth cesarean, and 67% with fift or more.6 Anyone case of Placenta previa associated with 2 to 5% risk of placenta accreta. For antenatal diagnosis of placenta accreta, primary modality is obstetrics ultrasound. There is 93% negative predictive value and 77% positive predictive value of ultrasound, described by Finberg et al.9 specificity and sensitivity of MRI in accuracy for placenta accreta spectrum prediction is 84.2% (95% CI, 76.0–89.8) and 94.6% (95% CI, 85.0–97.8) respectively, which is rationally good.10 Antenatal diagnosis of placenta accreta spectrum is considered crucial because it provides the time to plan management for improved outcomes, reducing the utilisation of resources like ICU stay and blood bank. Optimal management requires a systematic approach by an interdisciplinary integrative care team to manage the placenta accreta. The high risk group for placenta accreta spectrum should be screened in antenatal visit to avoid grave complications. Antepartum diagnosis can preserve fertility by conservative management to some extent. Methotrexate adjuvant treatment, Leaving the placenta in situ approach, preventive radiological and surgical uterine devascularization, systemic hysteroscopy resection of retained placenta, one step conservative surgery approach, triple –P procedure are method of conservative treatment of placenta accreta syndrome.

There are recommendations of conservative management of PAS (placenta accreta spectrum) disorder (Table 1)11

Our case is suspected as placenta Previa with placenta accreta on the basis of torrential haemorrhage with retained placenta and previous 3 cesarean deliveries and diagnosis of placenta accreta is confirmed by histopathology reports.

Conclusion

The postabortal haemorrhage can be potential critical emergency conditions for patient and decision-making situation for obstetrician that associated with maternal mortality and morbidity. Hysterectomy remains common procedure for placenta accreta spectrum but early identification and quick decision and timely intervention can save a life. This case highlights need for early diagnosis of placental accreta spectrum and to prevent the risk of massive haemorrhage.

Source of Funding

None.

Conflict of Interest

None.

References

1 

E Jauniaux F Chantraine RM Silver J Langhoff-Roos FIGO consensus guidelines on placenta accreta spectrum disorders: EpidemiologyInt J Gynaecol Obstet2018140326573

2 

CA Armstrong S Harding T Matthews JE Dickinson Is placenta accreta catching up with us?Aust N Z J Obstet Gynaecol20044432103

3 

MF Mogos JL Salemi M Ashley VE Whiteman HM Salihu Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998-2011J Matern Fetal Neonatal Med1998297107782

4 

S Shnider G Levinson Anesthesia for ObstetricsWilliams and WilkinsUSA1993

5 

DA David JA Chollet TM Goodwin Clinical risk factors for placenta previa-placenta accretaAm J Obstet Gynecol199717712104

6 

RM Silver MB Landon DJ Rouse KJ Leveno CY Spong EA Thom Maternal morbidity associated with multiple repeat cesarean deliveriesObstet Gynecol20061076122632

7 

S Wu M Kocherginsky JU Hibbard Abnormal placentation: twenty-year analysisAm J Obstet Gynecol20051925145861

8 

NE Marshall R Fu JM Guise Impact of multiple cesarean deliveries on maternal morbidity: a systematic reviewAm J Obstet Gynecol20112053262

9 

HJ Finberg JW Williams Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean sectionJ Ultrasound Med199211733343

10 

TF Esakoff TN Sparks AJ Kaimal LH Kim VA Feldstein RB Goldstein Diagnosis and morbidity of placenta accretaUltrasound Obstet Gynecol20113733247

11 

L Sentilhes G Kayem E Chandraharan J Palacios-Jaraquemada FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative managementInt J Gynaecol Obstet201814032918



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Case Report


Article page

362-365


Authors Details

Arti Gautam*, Neeru Malik, Sandhya Jain


Article History

Received : 22-02-2023

Accepted : 11-04-2023


Article Metrics


View Article As

 


Downlaod Files